News

 

September 1, 2014

AA139 to be presented at ICAAC 2014


Oktober 22, 2013,

BioCentury, Adenium: Lugworms vs. superbugs


May 17, 2013,

MedWatch, Biotekfirma får brug for ny kapital


June 14, 2012,

Børsen, Venturefirma sender biotekbabyer i krysild


June 13, 2012,

Medicon Valley, Sunstone Capital joins Adenium Biotech in the battle against multiresistent bacteria


June 06, 2012,

Berlingske, Investorer tror på sandormsmedicin


June 06, 2012,

Medwatch, Novo og Sunstone til kamp mod multiresistente bakterier


June 05, 2012,

Press release, Sunstone Capital går sammen med Adenium Biotech i kampen mod multiresistente bakterier


December 09, 2011,

Ingenøren; Sandorme giver stof til super-antibiotikum


December 09, 2011,

Berlingske Business; Vestjyske sandorme bag nyt dansk biotekselskab


August 22nd, 2011.

Novo A/S and Novozymes A/S have today agreed the financial terms governing the spin out of the Arenicin-3 family including variant library from Novozymes A/S to Adenium Biotech ApS.


August 17th, 2011.

Novo A/S has today established Adenium Biotech ApS through a Seed Financing.